Personalis
PSNL----
Personalis (PSNL)
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Perso...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Personalis Analyst Rating
View MoreForecast & Rating
Jul 20, 2026Price forecast
$13.8817.78%
Forecast & RatingBuy
6analysts
- Strong buy66.67%
- Buy0.00%
- Hold33.33%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · Jul 21 at 01:52 PM
Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoring
- PR Newswire · Jul 21 at 01:50 PM
Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders?
- prnewswire · Jul 21 at 12:55 PM
13:54 ET$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Personalis, Inc. (NASDAQ: PSNL)
- PUBT · Jul 20 at 07:32 AM
Tempus AI agrees to buy Personalis for USD 16.25 per share in USD 1.5 billion deal
- Tip Ranks · Jul 20 at 03:18 PM
Tempus AI (TEM) Drops on $1.7B Personalis Deal; Needham Analyst Calls the Slide a "Market Misread"
- benzinga_article · Jul 20 at 01:40 PM
Cathie Wood’s Tempus AI Bet Is Bleeding — And the Chart Looks Worse Than Wall Street Thinks
